Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Neurovirol. 2018 Nov 26;25(2):150–161. doi: 10.1007/s13365-018-0696-3

Figure 3. Cognitive status and Gal-9 levels.

Figure 3.

Gal-9 levels in the CSF and plasma were compared in younger and older HIV-infected CSF viremic individuals with normal cognition (NL)/neuropsychologic abnormal cognition (NP), minor cognitive motor disorder (MCMD), or HIV-associated dementia (HAD). Differences between groups were analyzed by Mann-Whitney tests. Statistical significance is indicated as *p<0.05, **p<0.01, ***p<0.001.